Dextromethorphan/quinidine for the treatment of bulbar impairment in amyotrophic lateral sclerosis.
Sign Up to like & getrecommendations! Published in 2023 at "Annals of clinical and translational neurology"
DOI: 10.1002/acn3.51821
Abstract: OBJECTIVE No efficacious treatments exist to improve or prolong bulbar functions of speech and swallowing in persons with amyotrophic lateral sclerosis (pALS). This study evaluated the short-term impact of dextromethorphan/quinidine (DMQ) treatment on speech and… read more here.
Keywords: bulbar; dextromethorphan quinidine; lateral sclerosis; dmq ... See more keywords